| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |